Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01400893 · ClinicalTrials.gov registry record · NA
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
A NA study, sponsored by SeaStar Medical.
- Terminated
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT01400893: Clinical Trial NA study, sponsored by SeaStar Medical.
NCT01400893 is a NA study that was terminated before completion, run by SeaStar Medical. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01400893, a NA study, was terminated before completion, sponsored by SeaStar Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
The purpose of this protocol is to evaluate the safety of a selective cytopheretic device (SCD) in patients that are on continuous renal replacement therapy (CRRT) for acute kidney injury (AKI).
Primary Outcome
All cause mortality through day 60 post-randomization. The outcome data reported here describe the mortality at Day 60 (primary endpoint) of the treated subjects which received the recommended ionized calcium (riCa) for ≥ 90% of treatment time.
Interventions
- DEVICE SCD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-09 |
| Phase | NA |
Why NCT01400893 stopped before completion
NCT01400893 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which SCD is the first listed.
NCT01400893 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01400893 about?
NCT01400893 is a clinical study titled "Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury". The purpose of this protocol is to evaluate the safety of a selective cytopheretic device (SCD) in patients that are on continuous renal replacement therapy (CRRT) for acute kidney injury (AKI).
What is the current status of trial NCT01400893?
This trial is currently terminated. It is a NA study. The enrollment target is 134 participants. The study started on 2011-08. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01400893?
The interventions under investigation include: SCD (DEVICE).
Who is sponsoring clinical trial NCT01400893?
This trial is sponsored by SeaStar Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01400893's enrollment target sits among peer trials
134 728th of 2000 higher than 1,272 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia